Pricing Log in Create free account

Lucy Scientific Discovery Inc. (LSDIF) vs PainReform Ltd. (PRFX)

Lucy Scientific Discovery Inc. and PainReform Ltd. are both Drug Manufacturers Specialty & Generic companies. PainReform Ltd. is the larger, with a market value of $2.6M against $900.0K — 2.9× the size. Across the 7 metrics below, Lucy Scientific Discovery Inc. leads on 4 and PainReform Ltd. on 3.

Valuation

Metric LSDIF PRFX Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S n/m n/m 2.11
P/B n/m 0.00 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m 0.97 12.58
EV/Sales n/m n/m 2.73
Earnings yield 0.00% (73,121.23%) (4.38%)
Free cash flow yield 0.00% (95,565.78%) 0.00%

Profitability

Metric LSDIF PRFX Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 0.00% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 337.20% 0.00% (0.40%)
Return on assets (249.36%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LSDIF PRFX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 10.01%
EPS growth (last fiscal year) (4.46%) 92.92% 49.06%
Revenue growth, 5-year CAGR — — 6.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LSDIF PRFX Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 0.38 5.07 2.31
Net debt to EBITDA 0.29 0.96 0.97

Dividend

Metric LSDIF PRFX Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric LSDIF PRFX Drug Manufacturers Specialty & Generic median
Market cap 900.00k 2.57m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack